We are live on ! Find out more
SYRS

Syros Pharmaceuticals, Inc. Common Stock

Delisted

SYRS was delisted on the 19th of March, 2025.

Name Holding Trade Value Shares
Change
Change in
Stake
Fidelity Investments
1
Fidelity Investments
Massachusetts
$60.1M +$1.87M +16,141 +3%
FP
2
Flagship Pioneering
Massachusetts
$38.2M
AIM
3
ARK Investment Management
Florida
$26.5M +$4.9M +42,232 +23%
RG
4
Redmile Group
California
$19.7M +$289K +2,490 +2%
BlackRock
5
BlackRock
New York
$19.2M +$348K +3,004 +2%
DM
6
Deerfield Management
New York
$15.1M
Vanguard Group
7
Vanguard Group
Pennsylvania
$12.4M +$505K +4,356 +4%
BBA
8
Baker Bros. Advisors
New York
$6.85M
State Street
9
State Street
Massachusetts
$4.55M +$349K +3,011 +9%
JP Morgan Chase
10
JP Morgan Chase
New York
$4.41M +$96.2K +829 +2%
T. Rowe Price Associates
11
T. Rowe Price Associates
Maryland
$3.9M -$3.13K -27 -0.1%
Northern Trust
12
Northern Trust
Illinois
$3.62M +$329K +2,835 +10%
Geode Capital Management
13
Geode Capital Management
Massachusetts
$2.7M +$133K +1,149 +5%
CS
14
Candriam SCA
Luxembourg
$2.43M
Millennium Management
15
Millennium Management
New York
$2.06M -$2.35M -20,262 -54%
Dimensional Fund Advisors
16
Dimensional Fund Advisors
Texas
$1.79M +$1.74M +15,035 New
EAM
17
Eventide Asset Management
Massachusetts
$1.79M
Charles Schwab
18
Charles Schwab
California
$1.54M +$197K +1,697 +15%
Connor, Clark & Lunn Investment Management (CC&L)
19
Connor, Clark & Lunn Investment Management (CC&L)
British Columbia, Canada
$1.41M +$186K +1,600 +16%
PAM
20
Panagora Asset Management
Massachusetts
$1.12M
BCM
21
Bridgeway Capital Management
Texas
$1.02M
Point72 Asset Management
22
Point72 Asset Management
Connecticut
$975K -$985K -8,496 -51%
GCP
23
GSA Capital Partners
United Kingdom
$969K +$490K +4,220 +108%
Jacobs Levy Equity Management
24
Jacobs Levy Equity Management
New Jersey
$939K +$25.5K +220 +3%
Bank of New York Mellon
25
Bank of New York Mellon
New York
$925K +$81.9K +706 +10%